Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Professor of Pharmacology and Toxicology at Indiana University Cancer Research Institute, Indianapolis
Ahmed Mostafa MD, MSc, PhD, is Director (in training) of ASHI Certified Histocompatibility, Training Program Tissue Typing Laboratory, Department of Pathology, Laboratory Medicine Calgary, Laboratory Services & at University of Calgary.
He is a Member of American Society for Histocompatibility and Immunogenetics (ASHI), Canadian Society for Immunology, Beatrice Hunter Cancer Research Institute, European Association of Cancer Research, American Association of Cancer Research, Canadian Society for Life Science Research, Tumor Microenvironment Working Group and American Society of Clinical Oncology.
Department of Diagnostic Radiology, MD Anderson Cancer Center, USA
Postdoc at National Institute of Health (NIH)/ National Cancer Institute (NCI), Clinical Center, Bethesda
Oncologist researcher for clinical/translational projects in HCC and pancreatic cancer patients, Medical Oncology Unit,
National Cancer Institute IRCCS "Giovanni Paolo II",
Professor, National Cancer Institute IRCCS "Giovanni Paolo II", Italy
Professor and Vice Chair, Department of Radiation Oncology
Director, Radiation Physics
Fox Chase Cancer Center
Room P-0069, 333 Cottman Ave.
Philadelphia, PA 19111, USA
Radiation Oncologist, SBRT and Neuro Oncology Programs, Jurvanski Cancer Center, Canada.
Professor,The Fels Institute for Cancer Research and Molecular biology, Medical Genetics & Molecular Biochemistry Department, Temple Univ. School of Medicine, USA.
Director, Biomarker Research Program; Professor, Institute of Academic Medicine; Professor, Weill Cornell Medical College,New York; Member, Houston Methodist Cancer Center; Visiting Professor, Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, china
Postdoctoral research fellow, Department of Cell Developmental and Cancer Biology, Oregon Health and Science University, Portland, USA
Assistant Professor of Oncology, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA
Dana-Farber Cancer Institute Brigham and Women's Hospital, United States
Gene Regulation, Stem Cell and Cancer program Centre for Genomic Regulation (CRG), Barcelona, Spain, Email: [email protected]
Visiting Professor and Consultant,
Center for Radiation Oncology Research
Department of Experimental Radiation Oncology
The University of Texas MD Anderson Cancer Center
United States of America
Prof. Dr. Alireza Heidari, Ph.D., D.Sc.
Full Distinguished Professor and Academic Tenure of Chemistry &
Enrico Fermi Distinguished Chair in Molecular Spectroscopy &
Head of Cancer Research Institute (CRI) &
Director of the BioSpectroscopy Core Research Laboratory at
Faculty of Chemistry, California South University (CSU), Irvine, California, USA &
President of the American International Standards Institute (AISI)
Irvine, California, USA
Dana-Farber Cancer Institute, Harvard Medical School, USA
Institute of Cancer Therapeutics University of Bradford, UK.
Director of Research Center and Head of Pain Department, MAHAK Pediatric Cancer Treatment and Research Center, Iran
Professor, Cancer Research Center, Laboratory Animal Center, The Key Laboratory of Brain and Spinal Injury of Liaoning Province, Laboratory Animal Center, The First Affiliated Hospital of Liaoning Medical University, China.
University of North Lineberger Comprehensive Cancer Center, USA.
The University of Texas MD Anderson Cancer Center, USA.
Harvard Medical School
Chief, Division of Translational Therapeutics, Department of Medicine, Director of Translational Therapeutics, Cancer Research Institute, United States.
PhD Degree at Anhui Medical University. Major: Urology. Research focus: Glutamine metabolism and advanced prostate cancer.
Master Degree at Anhui Medical University. Major: Urology. Thesis topic: Expression and clinical significance of autophagy gene Beclin-1 in prostate cancer
Foundation IRCCS, Division of Medical Oncology, National Institute of Cancer, Italy
National Institute of Cancerology, mexico
Aichi Cancer Center, Japan
Research Associate, Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati OH, USA.
Radiation oncologist, Apollo Specialty Cancer Hospital, India
Memorial Sloan Kettering Cancer Center, USA
IRCCS Foundation, National Cancer Institute, Italy
University of Michigan Cancer Center, Ann Arbor, Michigan, USA
Post-Doctoral Fellow in department of Cancer Immunology,Augusta University,
Senior Consultant, Colorectal Surgery, Fortis Cancer Centre and Hospital, India.
Translational Molecular Pathology, UT MD Anderson Cancer Center, Life Sciences Plaza, Houston, TX, USA
The University of Texas M.D. Anderson Cancer Center, USA.
Postdoctoral Associate, Department of Hematology/ Immunology, Fox Chase Cancer Center, Philadelphia, USA
Professor, Medical Director, Dept of Radiation Oncology,Vanderbilt-Ingram Cancer Center,TN USA.
Assistant Professor of Medicine/Hematology-Oncology,
Department of Medicine,
UCLA David Geffen School of Medicine,
Jonsson Comprehensive Cancer Center,
BCNet International Working Group, International Agency for Research on Cancer, France
Division of Pediatrics,
The University of Texas
MD Anderson Cancer Center,
Computational Scientist, MD Anderson Cancer Center, Houston, USA
Scientist in Immuno-Oncology & Cancer Immunotherapy, Department of Immunology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Assistant Researcher (Assistant Professor) at the University of Hawaii Cancer Center, Honolulu, USA.
Foundation T. & L. de Beaumont Bonelli for cancer research, Napoli, Italy
Infectious Diseases Pediatrician, Research Professor, Department of Hematology and Oncology Pediatrics , Hospital Civil de Guadalajara, and Research Institute in Children and Adolescent Cancer, Universidad de Guadalajara, Guadalajara Jalisco, Mexico
National Cancer Institute, Mexico City
Assistant Professor in University of Hawaii Cancer Center, Honolulu, USA.
Scientist, Basavatarakam Indo-American Cancer Hospital and Research Institute Banjara Hills, Hyderabad, Telangana, India
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
Department of Biochemistry, Case Comprehensive Cancer Center, CASE WESTERN RESERVE UNIVERSITY, United States
Research associate, Department of Cancer Biology, The Scripps Research Institute, Florida, USA.
MKA Breast Cancer Clinic, Ankara, Turkey
Professor of Medical Oncology at Hacettepe University Cancer Institute.Turkey
D. Phil., studies in cancer (breast cancer biomarkers) University of Sussex (Brighton)/Imperial Cancer Research Fund, London, England
The University of Texas MD Anderson Cancer Center,
Department of Hematopathology,
The University of Texas MD Anderson Cancer Center, Department of Hematopathology, 1515 Holcombe, Houston, TX, USA.
Assistant Professor at the University of Hawaii Cancer Center in Honolulu, USA
Research associate, Department of Neurological Surgery, Helen Diller Cancer Research Building, University of California San Francisco
Institute of Cancer and Genetics, Cardiff University School of Medicine, British.
Senior Research Scientist, Cancer Science Institute of Singapore, National University of Singapore.
Assistant Professor,Department of Pharmacology, National University of Singapore, Centre for Translational Medicine, Singapore.
Department of Experimental Radiation Oncology,
Division of Radiation Oncology,
The University of Texas
MD Anderson Cancer Center,
Head & Senior Consultant,
National Cancer Centre, Singapore
Deputy Physician-in Chief Director, Medical Oncology Northwell Health Cancer Institute. Professor, Feinstein Institute for Medictial Research. Professor Medical Onclogy, Zucker School of Medicine, USA
Associate Scientist, Cancer Biology Research Center and Childrenâs Health Research Center, Sanford Research, USA.
National Cancer Centre,
Dept. Cellular and Mol. Biology,
Associate Professor working at the University of Hawaii Cancer Center, Honolulu,USA.
Research Associate, Dana-Farber Cancer Institute, Harvard University, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, USA.
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, UT MD Anderson Cancer Center, Houston, USA.
The Sidney Kimmel Comprehensive Cancer Center School of Medicine Johns Hopkins University, United States
Research Fellow, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Researcher, Eukaryotic Transcriptional Regulation Section, Mouse Cancer Genetics Program, National Cancer Institute, Frederick, USA
Epigenetics and Chromatin Biology Group, Gupta Lab, Cancer Research Institute, ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai, India
Inpatient Surgical Oncology Nurse Practitioner at Cancer Treatment Centers of America Newnan,GA. USA
Associate Professor, Division of Oral Biology and Medicine, School of Dentistry, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, USA, E-mail: [email protected]
The University of Texas MD Anderson Cancer Center, USA
Clinical Researcher,University of Texas
M.D.Anderson Cancer Center,
Yale Immunobiology/ Yale Cancer Center, Yale School of Medicine,USA
Consultant, Shandong cancer hospital affiliated to Shandong University, China.
Deputy Director at Pathology Department, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou, China.
Member of Pathology Committee, Zhejiang Medical Association
Member of Pathologists Committee, Chinese Laboratory Medicine Committee
Member of Cancer Target Therapy Committee, Chinese Anti-Cancer Association
Member of Molecular Pathology Group, Pathology Quality Control Center of China
Member of Molecular Pathology Committee, Chinese Pathologist Association
Member of Molecular Pathology Committee, Chinese Society of Pathology
Research Scholar, Cancer Pharmacology Division, Indian Institute of Integrative Medicine (IIIM), Canal Road Centre of Scientific & Indusrial Research (Govt of India), Jammu Tawi- India.
Clinician Scientist and Consultant in Medical Oncology, The Institute of Cancer Research (ICR) and Royal Marsden Hospital (RMH) in London
Department of Cancer Genetics,
Roswell Park Cancer Institute,
Elm and Carlton Streets,
Buffalo, NY 14263,
Assistant Professor, Department of Orthopaedic Surgery, University of Maryland, Greenebaum Cancer Center, Baltimore, USA.
Professor in Surgery and Tumour Biology Director, Cardiff University-Peking University Cancer Institute, Cardiff
Director, Cardiff-Capital Medical Joint Centre for Biomedical Research, Cardiff University
Dean of International, Cardiff University
Professor and Deputy Director, State Local Joint Engineering Laboratory for Anticancer Drugs, Hunan Engineering Laboratory for Structural Biology and Drug Design, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, China.
Department of Cancer Biology, School of Medicine, University of Vanderbilt, United States
Assistant Professor, Cancer Epidemiology Program, University of Hawaii Cancer Center,USA.
President, Ooki Memorial Kikuchi Cancer Institue for Women,
Assistant Professor, Allogeneic BMT Princess Margaret Cancer Center, Toronto, Canada.
Author(s): Reback Theo
Author(s): Philipa Amoako
Author(s): Jean-claude Perez
Author(s): Edwina N Scott
Barbosa de Sena